Oral administration of a GPR81-specific agonist in a mouse model of colitis limited the differentiation of Th1 and Th17 cells and induced the differentiation of regulatory T cells to inhibit intestinal inflammation [157]. This evidence concerns the gene HCAR1 and colitis.